Reply to: "AI Technologies for Patients With Immune-Related Adverse Events"
J Thorac Oncol
.
2025 Mar;20(3):e48-e49.
doi: 10.1016/j.jtho.2025.01.004.
Authors
David O'Reilly
1
,
Caroline O'Leary
2
,
Jarushka Naidoo
3
Affiliations
1
Beaumont RCSl Cancer Centre, Dublin Ireland.
2
Trinity St. James's Cancer Institute, Dublin, Ireland.
3
Beaumont RCSI Cancer Centre, Dublin, Ireland; Sidney Kimmel Comprehensive Cancer Centre, John Hopkins University, Baltimore, Maryland. Electronic address: jarushkanaidoo@beaumont.ie.
PMID:
40049772
DOI:
10.1016/j.jtho.2025.01.004
No abstract available
Publication types
Letter